Plain-English translation of NCT07095842 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether , added to an existing seizure medication called , can stop severe, prolonged seizures more effectively in children with epilepsy. Right now, doctors give first, but it doesn't work for about one in three children. This study wants to see if adding the medication early — even before reaching the hospital — can help stop these dangerous seizures faster and prevent serious brain damage.
Severe, prolonged seizures that don't respond to standard medications can cause permanent brain injury and even death. There are often long delays before children reach a hospital and receive treatment, especially in areas with limited emergency services. This trial aims to find out if starting this treatment earlier, in the ambulance or at home, can prevent these serious complications.
You likely qualify if…
You likely don't qualify if…
If your child experiences a severe seizure that qualifies them for the study, paramedics or emergency personnel will administer either the medication combination or the standard treatment according to the study protocol, likely beginning in the prehospital setting (ambulance or before hospital arrival). Your child will then be monitored in the hospital, and the research team will track whether the seizure stops and how quickly. The study involves 668 children total, and your participation would include allowing researchers to document your child's seizure response and outcomes.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Egypt